Katarzyna Kotulska Selected Research

Tuberous Sclerosis (Bourneville's Disease)

11/2022	Distinct DNA Methylation Patterns of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex.
6/2022	mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile.
1/2022	Evolution of electroencephalogram in infants with tuberous sclerosis complex and neurodevelopmental outcome: a prospective cohort study.
1/2022	Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex.
1/2022	Association of Early MRI Characteristics With Subsequent Epilepsy and Neurodevelopmental Outcomes in Children With Tuberous Sclerosis Complex.
1/2022	Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period.
10/2021	MicroRNA-34a activation in tuberous sclerosis complex during early brain development may lead to impaired corticogenesis.
10/2021	A multistep approach to the genotype-phenotype analysis of Polish patients with tuberous sclerosis complex.
6/2021	New Insights into Red Blood Cell Microcytosis upon mTOR Inhibitor Administration.
5/2021	mTOR controls endoplasmic reticulum-Golgi apparatus trafficking of VSVg in specific cell types.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katarzyna Kotulska Research Topics

Disease

64	Tuberous Sclerosis (Bourneville's Disease) 11/2022 - 02/2004
29	Astrocytoma (Pilocytic Astrocytoma) 11/2022 - 02/2004
21	Epilepsy (Aura) 01/2022 - 04/2011
20	Neoplasms (Cancer) 01/2021 - 12/2003
19	Seizures (Absence Seizure) 01/2022 - 08/2007
11	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 02/2004
8	Drug Resistant Epilepsy 01/2022 - 04/2011
7	Glioma (Gliomas) 12/2021 - 01/2011
6	Brain Neoplasms (Brain Tumor) 11/2022 - 04/2010
6	Intellectual Disability (Idiocy) 01/2022 - 09/2011
5	Autism Spectrum Disorder 01/2022 - 12/2016
5	Angiomyolipoma 06/2016 - 01/2007
5	Neuralgia (Stump Neuralgia) 11/2011 - 01/2006
4	Neurocutaneous Syndromes (Phakomatoses) 01/2020 - 08/2007
4	Carcinogenesis 01/2020 - 04/2010
4	Hamartoma 01/2020 - 08/2007
4	Neuroma 11/2011 - 01/2006
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 10/2015
3	Autistic Disorder (Autism) 01/2020 - 01/2017
3	Peripheral Nerve Injuries 07/2007 - 01/2006
2	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 07/2022 - 01/2021
2	Diarrhea 01/2021 - 01/2021
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021 - 01/2021
2	Infections 01/2021 - 04/2015
2	Ganglioglioma 01/2021 - 06/2018
2	Hydrocephalus (Hydrocephaly) 01/2020 - 12/2014
2	Brain Diseases (Brain Disorder) 03/2016 - 01/2016
2	Angiofibroma 01/2016 - 07/2013
2	Rhabdomyoma 07/2013 - 03/2009
1	Neurodevelopmental Disorders 10/2021
1	Hyperglycemia 01/2021
1	Sleepiness 01/2021
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2021
1	Multiple Sclerosis 01/2021
1	Autoimmune Diseases of the Nervous System 01/2021
1	Bronchitis 01/2021
1	Anemia 01/2021
1	Infantile Spasms (West Syndrome) 01/2021
1	Stomatitis 01/2021
1	Neutropenia 01/2021
1	Cognitive Dysfunction 10/2020
1	Focal Cortical Dysplasia 01/2019
1	Temporal Lobe Epilepsy 01/2019
1	Disseminated Intravascular Coagulation 01/2019
1	Hyperlipidemias (Hyperlipidemia) 10/2016
1	Bacteremia 01/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Sepsis (Septicemia) 04/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2015
1	Demyelinating Diseases (Demyelinating Disease) 07/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2013

Drug/Important Bio-Agent (IBA)

54	trans-sodium crocetinate (crocetin)IBA 11/2022 - 12/2004
18	Everolimus FDA Link 06/2022 - 01/2012
14	TOR Serine-Threonine KinasesIBA 06/2021 - 01/2007
9	Pharmaceutical PreparationsIBA 01/2022 - 04/2011
8	Sirolimus (Rapamycin)FDA Link 11/2022 - 03/2009
7	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 08/2007
7	Vigabatrin FDA Link 01/2022 - 09/2018
6	Tuberous Sclerosis Complex 2 ProteinIBA 01/2018 - 02/2004
6	Tuberous Sclerosis Complex 1 ProteinIBA 01/2018 - 02/2004
5	Mechanistic Target of Rapamycin Complex 1IBA 10/2021 - 01/2017
4	MicroRNAs (MicroRNA)IBA 06/2022 - 09/2016
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 04/2010
4	MTOR InhibitorsIBA 12/2016 - 01/2016
2	nusinersenIBA 07/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2019
2	ChromatinIBA 12/2021 - 01/2021
2	CytokinesIBA 07/2013 - 08/2012
2	Mitochondrial DNA (mtDNA)IBA 01/2013 - 04/2011
2	Analgesics (Analgesic Drugs)IBA 07/2007 - 01/2006
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2007 - 01/2006
2	trkB ReceptorIBA 01/2007 - 01/2006
1	Cell Adhesion MoleculesIBA 01/2022
1	IronIBA 06/2021
1	Histones (Histone)IBA 01/2021
1	Oligoclonal BandsIBA 01/2021
1	CannabidiolIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	EnzymesIBA 01/2021
1	RecQ HelicasesIBA 10/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Ion Channels (Ion Channel)IBA 01/2019
1	LipidsIBA 10/2016
1	Oleic Acid (Oleate)IBA 02/2016
1	Growth Hormone (Somatotropin)IBA 02/2016
1	Alkaline PhosphataseIBA 01/2016
1	I-kappa B KinaseIBA 10/2015
1	Glutamate-Cysteine LigaseIBA 07/2015
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2013
1	Macrophage Colony-Stimulating FactorIBA 07/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2012
1	Endothelin-1 (Endothelin 1)IBA 08/2012

Therapy/Procedure

16	Therapeutics 01/2021 - 02/2006
4	Drug Therapy (Chemotherapy) 01/2019 - 06/2007
1	Treatment Delay 01/2021
1	Vagus Nerve Stimulation 01/2021
1	Aftercare (After-Treatment) 10/2016
1	Ketogenic Diet 02/2016
1	Topical Administration 01/2016